BEAM Alliance
General Information
Identification Code: 989919136810-31
Website: [object Object]
Entity Form: Association non profit (French - loi 1901)
Registration Category: Trade and business associations
Registration Date: 12/16/2019
Last Update: 11/28/2023
EP Accredited Number: 0
Mission & Interests
Goals: Since its inception in 2016, the BEAM Alliance has succeeded in uniting European Small Medium Enterprises (SMEs) working in the field of antimicrobial resistance (AMR). SMEs are recognized as the driving force of today’s innovation in the field of unmet medical need but are facing a now well acknowledged market failure. The BEAM Alliance gives its members a unique voice to propose and support policies and incentives in Europe to fix the market failure. The ultimate goal is to create market conditions attractive enough to pull back the needed support from investors and industrial partners, key stakeholders to bring medicine candidates from R&D stages to the patient.
For most stakeholders in the field of AMR (including governments, patients, industry representatives and other policy makers), BEAM is now recognised as a unique contributor helping our understanding of the complex array of cross-disciplinary issues (science, finance, and policymaking).
Interests Represented: Promotes their own interests or the collective interests of their members
Interests:
- Business and industry
- Public health
- Research and innovation
Levels of Interest:
- european
Activities
Main EU Legislative Proposals: The BEAM Alliance is following any legal and regulatory actions intended to improve the current antimicrobial resistance (AMR) market landscape. The BEAM Alliance has thus a special interest in so-called “PULL incentives” that can facilitate the market uptake of innovative solutions against AMR. PULL incentives include financial rewards, improved valuation and pricing methodologies or reimbursement mechanisms. The BEAM Alliance also has a special focus on funding instruments able to de-risk R&D activities (so-called “PUSH incentives”). From a wider perspective, the BEAM Alliance follows all evolutions linked to the fight against AMR (stewardship policies, access to critical medicine, etc.) and more generally policies related to SMEs and innovation.
In that regard the BEAM Alliance is interacting with the EU institutions in relation to the following files and policies:
EU Action on Antimicrobial Resistance
Pharmaceutical Strategy for Europe
EU pharmaceutical legislation (Directive 2001/83/EC and Regulation (EC) No 726/2004)
Communication on “Building a European Health Union”
Europe’s Industrial Strategy
SME Strategy
EU R&D funding (Horizon 2020, Horizon Europe)
Communication Activities: As part of its activities, the BEAM Alliance is in constant interactions with stakeholders involved in the fight against AMR at the international (WHO, UN IACG, European Commission, EMA, ESCMID, EUCAST, Global AMR R&D Hub, etc.) and national (ministries of health) levels. The BEAM Alliance is mainly delivering its vision and propositions through position papers (https://beam-alliance.eu/our-actions/) and invited speakers to conferences and forums, such as the AMR conference (https://amr-conference.com/). The BEAM Alliance is also particularly active during the World Antibiotic Awareness Week (18-24 Nov), and aims at organising roundtables involving stakeholders from different horizons (including European Commission, European Parliament and other national representatives).
EU Supported Forums and Platforms: Antimicrobial Resistance One Health Network#E03853#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=3853 #MEMBER #C#SMEs
Inter-institutional or Unofficial Groupings: N/A
Head Office
Address: 29 Avenue Tony Garnier
Post Code: 69007
City: Lyon
Country: FRANCE
Phone: [object Object]
EU Office
Address: 29 Avenue Tony Garnier
Post Code: 69007
City: Lyon
Country: FRANCE
Phone: [object Object]
Financial Data
New Organisation: false
Closed Year: [object Object]
Current Year: [object Object]
Membership Information
Members10 Percent: 0
Members25 Percent: 1
Members50 Percent: 0
Members75 Percent: 1
Members: 2
Members F T E: 1
Info Members: Apart from the dedicated staff mentioned above, elected Board Members (7-8) (see https://beam-alliance.eu/ for details), all with active executive positions in their own companies, are contributing pro-bono to the BEAM Alliance actions.
Structure
Structure Type: Structure
Is Member Of: The BEAM Alliance has members from 2 types. Full members are private or public pure player SMEs developing products focused upon prevention, diagnosis and cure of microbial infections. Headquarters and main activities are located in Europe. Associated Organizations are private or public actors developing activities against AMR such as services, R&D, etc. The updated list of current members is available here: https://beam-alliance.eu/members/
Organisation Members: The BEAM Alliance is a member of the AMR Industry Alliance (https://www.amrindustryalliance.org) and of the AMR Stakeholder Network (https://epha.org/amr-stakeholder-network/)